Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hamed akbarzadeh[Author] (19 results)?
Microbiome as a biomarker and therapeutic target in pancreatic cancer.
Pourali G, Kazemi D, Chadeganipour AS, Arastonejad M, Kashani SN, Pourali R, Maftooh M, Akbarzade H, Fiuji H, Hassanian SM, Ghayour-Mobarhan M, Ferns GA, Khazaei M, Avan A. Pourali G, et al. Among authors: akbarzade h. BMC Microbiol. 2024 Jan 5;24(1):16. doi: 10.1186/s12866-023-03166-4. BMC Microbiol. 2024. PMID: 38183010 Free PMC article. Review.
The potential therapeutic applications of CRISPR/Cas9 in colorectal cancer.
Sahranavard T, Mehrabadi S, Pourali G, Maftooh M, Akbarzade H, Hassanian SM, Mobarhan MG, Ferns GA, Khazaei M, Avan A. Sahranavard T, et al. Among authors: akbarzade h. Curr Med Chem. 2023 Sep 15. doi: 10.2174/0929867331666230915103707. Online ahead of print. Curr Med Chem. 2023. PMID: 37724673
Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights.
Soleimani A, Saeedi N, Al-Asady AM, Nazari E, Hanaie R, Khazaei M, Ghorbani E, Akbarzade H, Ryzhikov M, Avan A, Mehr SMH. Soleimani A, et al. Among authors: akbarzade h. Curr Pharm Des. 2024 Apr 15. doi: 10.2174/0113816128291321240329050945. Online ahead of print. Curr Pharm Des. 2024. PMID: 38623972
The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers.
Keyvani V, Mollazadeh S, Riahi E, Mahmoudian RA, Tabari M, Lagzian E, Ghorbani E, Akbarzade H, Gholami AS, Gataa IS, Hassanian SM, Ferns GA, Khazaei M, Avan A, Anvari K. Keyvani V, et al. Among authors: akbarzade h. Curr Pharm Des. 2024 Mar 18. doi: 10.2174/0113816128291955240306112558. Online ahead of print. Curr Pharm Des. 2024. PMID: 38500284